A 48-year-old man with severe, refractory rheumatoid arthritis is treated with an intravenous infusion of a chimeric monoclonal antibody. Twelve days after the infusion, he presents to the urgent care clinic with a new-onset pruritic rash, spiking fevers, and severe joint pain in his knees and wrists. Laboratory testing shows reduced serum C3 and C4 levels, an elevated erythrocyte sedimentation rate, and new-onset proteinuria. Arrange the following immunopathologic events in the correct chronological sequence that led to this patient's current clinical presentation.
- 1Production of high-affinity IgG antibodies directed against the foreign murine peptide sequences of the biologic agent.
- 2Generation of circulating multivalent antigen-antibody aggregates during a period of relative antigen excess.
- 3Trapping and deposition of circulating macromolecules within the subendothelial spaces of small blood vessels.
- 4Binding of C1q to the Fc portion of deposited immunoglobulins and subsequent generation of C3a and C5a.
- 5Neutrophil infiltration, frustrated phagocytosis, and release of tissue-destructive lysosomal proteases.
Answer
The correct chronological sequence of this Type III hypersensitivity reaction begins with the production of host IgG antibodies against the drug, followed by the formation of circulating immune complexes in antigen excess. These complexes then deposit in small vessel subendothelial spaces, where they activate the classical complement cascade, which ultimately recruits neutrophils that cause tissue-destructive vasculitis.
Serum sickness is a classic systemic Type III hypersensitivity reaction. The precise chronological progression is required to understand the delayed nature of the symptoms and the specific laboratory findings. It mandates initial sensitization and IgG production against the foreign protein (Step 1). Because the drug antigen is present in high quantities, intermediate-sized circulating immune complexes form in a state of antigen excess (Step 2). These specific complexes evade typical phagocytic clearance and eventually deposit in areas of high vascular filtration like the renal glomeruli and synovial capillaries (Step 3). Once fixed, the Fc portions of the dense IgG clusters provide a scaffold for C1q binding, heavily activating the classical complement pathway and resulting in the observed hypocomplementemia (C3 and C4 consumption) while releasing C5a (Step 4). Finally, C5a recruits neutrophils, which attempt to phagocytose the basement membrane-bound complexes but instead cause destructive localized vasculitis via lysosomal enzyme release (Step 5).
Step-by-Step Solution
Key Concept
Pathogenesis of Systemic Type III Hypersensitivity (Serum Sickness)